BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Allergan Presented New Phase III Data of Ulipristal Acetate in Women with Uterine Fibroids at the ASRM Annual Congress

  Allergan presented new analyses of VENUS II, the second of two pivotal Phase III clinical trials evaluating the efficacy and safety of ulipristal acetate (UPA), an investigational drug for the treatment of abnormal uterine bleeding in women with uterine fibroids.

  October 31, 2017

   · 

  10 min read
• Business

  Sangamo Therapeutics Announces Third Quarter 2017 Conference Call and Webcast

  Sangamo Therapeutics announced today that the company will release its third quarter 2017 financial results after the market closes on Thursday, November 9, 2017.

  October 31, 2017

   · 

  1 min read
• Business

  ReShape Lifesciences to Host Third Quarter Conference Call on November 14, 2017

  ReShape Lifesciences today announced that it will host a conference call to discuss financial results for the third quarter of 2017 on Tuesday, November 14, 2017 at 1:30 PM Pacific Time.

  October 31, 2017

   · 

  1 min read
• 

  FDA

  Luminex Receives FDA Clearance for ARIES Group A Strep Assay

  This is the sixth assay the FDA has cleared for use on Luminex’s ARIES Systems in the last 24 months.

  October 31, 2017

   · 

  6 min read
• Business

  Regulus to Provide Third Quarter 2017 Financial Results on November 7, 2017

  Regulus will host a conference call and webcast on November 7, 2017 at 5:00 p.m. Eastern Time to discuss third quarter 2017 financial results and corporate highlights.

  October 31, 2017

   · 

  3 min read
• Drug Development

  PerkinElmer Release: Phase II Clinical Trial Data Establishes Effectiveness of Using A Child’s Own Cord Blood to Treat Cerebral Palsy

  The research from a Phase II clinical trial indicates that patients with CP who were treated with an infusion of an adequate dose of their own cord blood, which had been collected and stored at birth, saw a significant improvement in their motor function.

  October 31, 2017

   · 

  4 min read
• BIOCORP Won CPhI Pharma Awards 2017, in the “IT, mHealth and Digitalisation” Category, for Its Entire Connected Devices Range

  The event took place on October 24 at the Intercontinental Hotel in Frankfurt, Germany.

  October 31, 2017

   · 

  3 min read
• Lone Star Bio

  CorInnova Selected to Present at TCT 2017 “Shark Tank” Competition

  CorInnova’s presentation will be on Tuesday, Oct. 31, at 9:16 a.m. MST.

  October 31, 2017

   · 

  2 min read
• Deals

  Medicure Acquires Exclusive License to Sell and Market PREXXARTAN in the U.S. From Carmel Biosciences

  Medicure has acquired an exclusive license to sell and market PREXXARTAN (valsartan) oral solution in the U.S. and its territories from Carme for a seven year term with extensions to the term available.

  October 31, 2017

   · 

  4 min read
• Business

  Orexigen Therapeutics to Provide Business Update and Discuss Third Quarter 2017 Financial Results on November 13, 2017

  Orexigen will announce corporate and financial results for the third quarter of 2017 on Monday, November 13th after the market closes.

  October 31, 2017

   · 

  1 min read